Sessa Capital (Master), L.P. - Insider Trading & Ownership

Entity
Company
Location
888 Seventh Avenue, 30 Th Floor, New York, NY
Summary
The estimated value of insider holdings of Sessa Capital (Master), L.P. is at least $32.4M dollars as of November 28, 2023. Sessa Capital (Master), L.P. is the Director of SAB Biotherapeutics, Inc. and owns shares of SAB Biotherapeutics, Inc. (SABS) stock worth about $32.4M.
All Insider Reports
All Insider Reports

Ownership of Sessa Capital (Master), L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SABS, SABSW SAB Biotherapeutics, Inc. Director $32.4M Nov 24, 2023
PRVB Provention Bio, Inc. 10%+ Owner Apr 27, 2023

Insider Transactions Reported by Sessa Capital (Master), L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.